Combination Cisplatin and Dichloromethotrexate in Patients with Advanced Bladder Cancer. Phase 2. A Southwest Oncology Group Study-Reference-Cited by-同舟云学术

Combination Cisplatin and Dichloromethotrexate in Patients with Advanced Bladder Cancer. Phase 2. A Southwest Oncology Group Study

Published:1992-07 Issue:1 Volume:148 Page:52-54
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Meyers Frederick J.¹²³⁴⁵,Blumenstein Brent¹²³⁴⁵,Crawford E. David¹²³⁴⁵,Hynes Harry E.¹²³⁴⁵,Montie James E.¹²³⁴⁵,Taylor Sarah A.¹²³⁴⁵,Grossman H. Barton¹²³⁴⁵,Natale Ronald B.¹²³⁴⁵

Affiliation:

1. University of California, Davis, Sacramento, California

2. Southwest Oncology Group Statistical Center, Seattle, Washington

3. University of Colorado, Denver, Colorado

4. Wichita CCOP, Wichita, Kansas

5. Cleveland Clinic Foundation, Cleveland, Ohio

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference12 articles.

1. Chemotherapy of urothelial tract tumors;Yagoda;Cancer,1987

2. Cisplatin, methotrexate, and vinblastine (CMV): an effective chemotherapy regimen for metastatic transitional cell carcinoma of the urinary tract. A Northern California Oncology Group Study;Harker;J. Clin. Oncol.,1985

3. Combination chemotherapy with cisplatin and methotrexate in advanced transitional cell cancer of the bladder;Stoter;J. Urol.,1987

4. The multimodality approach to invasive transitional cell carcinoma of the bladder;Meyers,1989

5. Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium. Efficacy and patterns of response and relapse;Sternberg;Cancer,1989

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chemotherapy in Locally Advanced and Metastatic Bladder Cancer;European Urology Supplements;2004-03

2. Bewertung des Komplementärtherapeutikums Factor AF2 als Supportivum in der Behandlung des fortgeschrittenen Urothelkarzinoms Prospektiv randomisierte Multicenterstudie;Der Urologe A;2002-03

3. DOCETAXEL AND IFOSFAMIDE AS SECOND LINE TREATMENT FOR PATIENTS WITH ADVANCED OR METASTATIC UROTHELIAL CANCER AFTER FAILURE OF PLATINUM CHEMOTHERAPY: A PHASE 2 STUDY;Journal of Urology;2001-01

4. New approaches to treatment of metastatic bladder cancer;Current Oncology Reports;2000-10

5. New approaches in the treatment of metastatic transitional-cell cancer of the bladder;World Journal of Urology;1997-04